Teva Pharmaceutical Industries Ltd. Downgraded To #BB# On Continued Challenges To Outlook Stable

Stocks and Financial Services Press Releases Friday February 9, 2018 08:30
NEW YORK--9 Feb--S&P Global Ratings

NEW YORK (S&P Global Ratings) Feb. 8, 2018--S&P Global Ratings today lowered its long-term corporate credit rating on Israel-based Teva Pharmaceutical Industries Ltd. to 'BB' from 'BBB-' and removed the rating from CreditWatch, where we placed with negative implications on Feb. 2, 2018.

The outlook is stable. At the same time, we lowered our issue-level rating on the senior unsecured debt to 'BB' and assigned a '3' recovery rating to this tranche. We removed the issue-level rating from CreditWatch with negative implications.

The '3' recovery rating reflects our expectation for meaningful (50%-70%; rounded estimate 50%) recovery in the event of a payment default. The rating action on Teva reflects a series of lower-than-expected operating results following the 2016 acquisition of Actavis Generics for $33.4 billion in cash and additional equity. We initially believed the acquisition would deliver a material boost to Teva's future generic first-to-market performance, as well as provide a level of scale that would give Teva a competitive advantage over peers like Mylan and Perrigo.

In addition to revising our financial forecasts lower, the successive operating misses led us to lower our expectations for Teva's long-term stability and predictability. Our stable outlook reflects our expectation for substantial revenue declines from Copaxone and U.S. generics in 2018, but that cost cutting and more stable U.S. generics results by 2019 will support gradual deleveraging and still-significant free cash flow generation. We expect free cash flow of about $2.6 billion in 2018 and $2.2 billion in 2019, commensurate with average FFO to debt of about 12% from 2017-2019.


Latest Press Release

Indonesia#s Proposed Senior Unsecured Yen-Denominated Bonds Assigned #BBB-# Long-Term Foreign Currency Rating

SINGAPORE (S&P Global Ratings) May 24, 2018--S&P Global Ratings today assigned its 'BBB-' long-term foreign currency rating to the following Japanese yen-denominated fixed-rate senior unsecured bonds proposed by Indonesia...

Ratings Assigned To Cash Flow CLO Transaction Avoca CLO XVIII

LONDON (S&P Global Ratings) May 24, 2018--S&P Global Ratings today assigned its credit ratings to Avoca CLO XVIII DAC's class A, B-1, B-2, C, D, E, and F notes. At closing, Avoca also issued unrated subordinated notes (see list below). Avoca...

Credit Union Payment Center Outlook Revised To Positive On Resilient Results And Zero-Debt #BB/B# Affirmed

MOSCOW (S&P Global Ratings) May 24, 2018--S&P Global Ratings today revised its outlook to positive from stable on Russia-based Credit Union Payment Center (RNKO), a core subsidiary and payment settlement center for Center of Financial...

Longstone Finance Class A And B Notes Upgraded Following Lloyds Bank Upgrade

LONDON (S&P Global Ratings) May 24, 2018--S&P Global Ratings today raised its credit ratings on Longstone Finance PLC's class A and B notes. We took no action on the Class C notes (see list below). Today's upgrades follow our May 8, 2018, upgrade...

RESIMAC Triomphe Trust - RESIMAC Premier Series 2018-1 Prime RMBS Assigned Ratings

MELBOURNE (S&P Global Ratings) May 24, 2018--S&P Global Ratings today assigned its ratings to eight classes of prime residential mortgage-backed securities (RMBS) issued by Perpetual Trustee Co. Ltd. as trustee for RESIMAC Triomphe Trust -...

Related Topics